← Open Payments lookup

LISA VANDIEMEN: Open Payments

NPI 1396041885 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$639 in 27 payments from 7 companies in 2025. Trend: 2023 $547 · 2024 $510 · 2025 $639

Food & beverage: $639
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$167
ViiV Healthcare Company7$162
Neurocrine BioSciences, Inc.6$125
E.R. Squibb & Sons, L.L.C.2$72
Teva Pharmaceuticals USA, Inc.3$61
ABBVIE INC.1$33
Axsome Therapeutics, Inc.1$19

Products named: CAPLYTA, INGREZZA, CABENUVA, COBENFY, DOVATO, AUSTEDO XR, VRAYLAR, RUKOBIA.

Industry payments across TX — which companies pay providers there.